COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00137644
Recruitment Status : Completed
First Posted : August 30, 2005
Last Update Posted : January 7, 2010
Sponsor:
Collaborator:
Public Health Management Corporation
Information provided by:
Centers for Disease Control and Prevention

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this program evaluation is to determine whether the Preventing AIDS Through Live Movement and Sound (PALMS) group-level intervention is effective in reducing HIV sex risk behaviors and increasing HIV testing of high-risk, incarcerated or adjudicated youth. The intent of this program is to support the evaluation of an existing intervention and provide feedback to the implementing organization for improved program effectiveness, not to conduct research.

Condition or disease Intervention/treatment Phase
HIV Infections Behavioral: Preventing AIDS Through Live Movement and Sound (PALMS) Phase 1 Phase 2

Detailed Description:
Philadelphia Health Management Corporation (PHMC) is evaluating the Preventing AIDS Through Live Movement and Sound (PALMS) group-level intervention for high-risk, incarcerated or adjudicated youth. PALMS uses three theater-based sessions to increase knowledge about HIV/AIDS, increase HIV testing, and reduce risky sexual behavior through increased self-efficacy. The intervention is delivered by peers, and peers work with the intervention team to use evaluation results to improve the program. The evaluation will recruit male adolescents, aged 12 to 18 years, who are residing in juvenile justice or drug treatment facilities in Philadelphia. The evaluation design uses concurrent intervention (N=132) and comparison (N=132) groups. Data will be collected at baseline, immediate post-intervention, and at a 6-month post-intervention follow-up. The intent of this program is to support the evaluation of an existing intervention and provide feedback to the implementing organization for improved program effectiveness, not to conduct research.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 264 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Innovative HIV Prevention Intervention for Minority Adolescents by the Philadelphia Health Management Corporation in Philadelphia, PA
Study Start Date : March 2005
Actual Study Completion Date : January 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Sexual activity [ Time Frame: Within past 3 months & ever ]
  2. Number and type (main and non-main) of female sex partners [ Time Frame: Within past 3 months ]
  3. Frequency of condom use with female sex partners [ Time Frame: Within past 3 months ]
  4. HIV testing (ever tested, number of tests, likelihood of test) [ Time Frame: Within past 3 months ]

Secondary Outcome Measures :
  1. Drug use [ Time Frame: Within past 3 months ]
  2. Knowledge of HIV transmission, prevention and testing [ Time Frame: Concurrent ]
  3. Attitudes and beliefs about condoms and safe sex [ Time Frame: Concurrent ]
  4. Beliefs about HIV and HIV testing [ Time Frame: Concurrent ]
  5. Perception of HIV risk [ Time Frame: concurrent ]
  6. Self-efficacy to use condoms and practice safe sex [ Time Frame: Concurrent ]
  7. Self-esteem [ Time Frame: Concurrent ]
  8. Perceptions of cultural and peer norms [ Time Frame: Concurrent ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male adolescents
  • Between the ages of 12 and 18
  • Receiving residential services at juvenile justice or drug treatment facilities
  • African-American or Latino

Exclusion Criteria:

  • Do not speak English
  • Prior participation in PALMS intervention
  • Female adolescents
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00137644


Locations
Layout table for location information
United States, Pennsylvania
Philadelphia Health Management Corporation
Philadelphia, Pennsylvania, United States, 19102
Sponsors and Collaborators
Centers for Disease Control and Prevention
Public Health Management Corporation
Investigators
Layout table for investigator information
Principal Investigator: Jennifer Lauby, PhD Public Health Management Corporation
OverallOfficial: Jeffrey H Herbst, PhD Project Officer, Division of HIV/AIDS Prevention, NCHSTP, Centers for Disease Control and Prevention
OverallOfficial: Thomas M Painter, PhD Project Officer, Division of HIV/AIDS Prevention, NCHSTP, Centers for Disease Control and Prevention
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00137644    
Other Study ID Numbers: CDC-NCHSTP-CCU324516
U65/CCU324516
First Posted: August 30, 2005    Key Record Dates
Last Update Posted: January 7, 2010
Last Verified: January 2010
Keywords provided by Centers for Disease Control and Prevention:
Adolescent
*HIV Infections/ pc [Prevention & Control]
Male
Humans
Risk-Taking
 Safe Sex
Sexual Behavior
HIV
HIV Seronegativity
Additional relevant MeSH terms:
Layout table for MeSH terms
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
 Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases